Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

JAYDESS

BAYER INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is JAYDESS discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that JAYDESS 13.5MG has been permanently discontinued (last updated January 4, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is JAYDESS not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products · 1 same form & route
Affected strength13.5MG
Report last updated2019-01-04
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

MIRENA

BAYER INC

52MG · DIN 02243005

Different strengthSame dosage formSame routeNo current shortage

PLAN B

FOUNDATION CONSUMER HEALTHCARE, LLC

1.5MG · DIN 02293854

Different strengthDifferent dosage formDifferent routeNo current shortage

BACKUP PLAN ONESTEP

APOTEX INC

1.5MG · DIN 02433532

Different strengthDifferent dosage formDifferent routeNo current shortage

MYSTEP

JAMP PHARMA CORPORATION

1.5MG · DIN 02548461

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02408295

Strength

13.5MG

Dosage Form

INSERT (EXTENDED-RELEASE)

Route

INTRAUTERINE

Active Ingredient

LEVONORGESTREL

See all LEVONORGESTREL products →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History